• 1
    June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. (1994) The B7 and CD28 receptor families. Immunol Today 15, 321.
  • 2
    Linsley P.S., Greene J.L., Brady W., Bajorath J., Ledbetter J.A., Peach R. (1994) Human B7 (CD80) and B7 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793.
  • 3
    Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541.
  • 4
    Waterhouse P., Penninger J.M., Timms E. et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985.
  • 5
    Krummel M.F. & Allison J.P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182, 459.
  • 6
    Krummel M.F. & Allison J.P. (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183, 2533.
  • 7
    Walunas T.L., Bakker C.Y., Bluestone J.A. (1996) CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 183, 2541.
  • 8
    Perez V.L., Van Parijs L., Biuckians A., Zheng X.X., Strom T.B., Abbas A.K. (1996) Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411.
  • 9
    Walunas T.L., Lenschow D.J., Bakker C.Y. et al. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405.
  • 10
    Karandikar N.J., Vanderlugt C.L., Walunas T.L., Miller S.D., Bluestone J.A. (1996) CTLA-4: a negative regulator of autoimmune disease. J Exp Med 184, 783.
  • 11
    Perrin P.J., Maldonado J.H., Davis T.A., June C.H., Racke M.K. (1996) CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol 157, 1333.
  • 12
    Leach D.R., Krummel M.F., Allison J.P. (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734.
  • 13
    McCoy K., Camberis M., Gros G.L. (1996) Protective immunity to nematode infection is induced by CTLA-4 blockade. J Exp Med 186, 183.
  • 14
    Wu Y., Guo Y., Huang A., Zheng P., Liu Y. (1997) CTLA-4–B7 interaction is sufficient to costimulate T cell clonal expansion. J Exp Med 185, 1327.
  • 15
    Linsley P.S., Greene J.L., Tan P. et al. (1992) Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 176, 1595.
  • 16
    Gribben J.G., Freeman G.J., Boussiotis V.A. et al. (1995) CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92, 811.
  • 17
    Blair P.J., Riley J.L., Levine B.L. et al. (1998) CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X-L induction. J Immunol 160, 12.
  • 18
    Vandenborre K., Delabie J., Boogaerts M.A. et al. (1998) Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft- versus-host disease and in Hodgkin’s disease. Am J Pathol 152, 963.
  • 19
    Vandenberghe P. & Ceuppens J.L. (1991) Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5. Eur J Immunol 21, 251.
  • 20
    Romani N., Reider D., Heuer M. et al. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196, 137.
  • 21
    Bullens D.M.A., Kasran A., Peng X., Lorre K., Ceuppens J.L. (1998) Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors. Clin Exp Immunol 113, 320.
  • 22
    Van Gool S.W., Ceuppens J.L., Walter H., De Boer M. (1994) Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. Blood 83, 176.
  • 23
    Fallarino F., Fields P.E., Gajewski T.F. (1998) B7 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J Exp Med 188, 205.
  • 24
    Lin H., Rathmell J.C., Gray G.S., Thompson C.B., Leiden J.M., Alegre M.L. (1998) Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med 188, 199.